Co-Diagnostics, Inc.(NASDAQ:CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that CoSara Diagnostics Pvt Ltd (“CoSara,” or the “JV”), its joint venture for manufacturing and sales in India, has received clearance by the Central Drugs Standard Control Organization (“CDSCO”) in India to manufacture and sell its SARAGENE™ Human Papillomavirus High-Risk (HPV-HR) Real-Time PCR test as an in vitro diagnostic (“IVD”).
These Are The Top 5G Funds
In these crazy, Covid-ridden times, it would seem that 5G’s popularity only comes from its association with conspiracy theories. However, its transformational power is equivalent to that of AI, autonomous vehicles, and outer space traveling, as it will change how we live or the jobs our children will have.
